CCR2 Receptor is Essential to Activate Microbicidal Mechanisms to Control Toxoplasma Gondii Infection in the Central Nervous System

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2008 Aug 9

PMID 18688032

Citations 24

Authors

Luciana Benevides

Cristiane Maria Milanezi

Lucy Megumi Yamauchi

Claudia Farias Benjamim

Joao Santana Silva

Neide Maria Silva

Affiliations

Soon will be listed here.

Abstract

Chemokines comprise a structurally related family of cytokines that regulate leukocyte trafficking. Because infection with Toxoplasma gondii can induce an important inflammatory reaction that, if left uncontrolled, can lead to death, we investigated the role of the chemokine receptor CCR2 in T. gondii infection. We orally infected CCR2(-/-) mice with five ME-49 T. gondii cysts and monitored morbidity, survival, and immune response thereafter. The CCR2(-/-) mice displayed higher susceptibility to infection as all mice died on day 28 after infection. Despite similar Th1 responses, a more evident anti-inflammatory response was induced in the peripheral organs of CCR2(-/-) mice compared with wild-type C57BL/6 mice. Additionally, CCR2(-/-) mice presented greater parasitism and a milder inflammatory reaction in their peripheral organs with lesser CD4(+) and MAC-1(+) and greater CD8(+) cell migration. The parasite load decreased in these organs in CCR2(-/-) mice but remained uncontrolled in the central nervous system. Additionally, we observed down-regulated inducible nitric oxide synthase expression in peripheral organs from CCR2(-/-) mice that was associated with a small nitric oxide production by spleen macrophages. In conclusion, in the absence of CCR2, another mechanism is activated to control tissue parasitism in peripheral organs. Nevertheless, CCR2 is essential for the activation of microbicidal mediators that control T. gondii replication in the central nervous system.

Citing Articles

Pathological mechanisms of glial cell activation and neurodegenerative and neuropsychiatric disorders caused by infection.

Yang Z, Chen J, Zhang C, Peng H Front Microbiol. 2024; 15:1512233.

PMID: 39723133 PMC: 11668811. DOI: 10.3389/fmicb.2024.1512233.

Distinct cytokine profiles in malaria coinfections: A systematic review.

Kotepui M, Mala W, Kwankaew P, Kotepui K, Masangkay F, Wilairatana P PLoS Negl Trop Dis. 2023; 17(1):e0011061.

PMID: 36716305 PMC: 9886258. DOI: 10.1371/journal.pntd.0011061.

Behavioral alterations in long-term Toxoplasma gondii infection of C57BL/6 mice are associated with neuroinflammation and disruption of the blood brain barrier.

Barrios L, Pinheiro A, Gibaldi D, Silva A, Rodrigues e Silva P, Roffe E PLoS One. 2021; 16(10):e0258199.

PMID: 34610039 PMC: 8491889. DOI: 10.1371/journal.pone.0258199.

Morphological and biochemical repercussions of infection in a 3D human brain neurospheres model.

Leite P, de Araujo Portes J, Pereira M, Russo F, Martins-Duarte E, Almeida Dos Santos N Brain Behav Immun Health. 2021; 11:100190.

PMID: 34589727 PMC: 8474451. DOI: 10.1016/j.bbih.2020.100190.

CCR2 Deficiency Impairs Ly6C and Ly6C Monocyte Responses in Infection.

Petermann M, Orfanos Z, Sellau J, Gharaibeh M, Lotter H, Fleischer B Front Immunol. 2021; 12:670219.

PMID: 34290699 PMC: 8287586. DOI: 10.3389/fimmu.2021.670219.

References

Brenier-Pinchart M, Villena I, Mercier C, Durand F, Simon J, Cesbron-Delauw M . The Toxoplasma surface protein SAG1 triggers efficient in vitro secretion of chemokine ligand 2 (CCL2) from human fibroblasts. Microbes Infect. 2005; 8(1):254-61. DOI: 10.1016/j.micinf.2005.06.023. View

Mennechet F, Kasper L, Rachinel N, Li W, Vandewalle A, Buzoni-Gatel D . Lamina propria CD4+ T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen. J Immunol. 2002; 168(6):2988-96. DOI: 10.4049/jimmunol.168.6.2988. View

Gazzinelli R, Hakim F, Hieny S, Shearer G, Sher A . Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol. 1991; 146(1):286-92. View

Stenstad H, Svensson M, Cucak H, Kotarsky K, Agace W . Differential homing mechanisms regulate regionalized effector CD8alphabeta+ T cell accumulation within the small intestine. Proc Natl Acad Sci U S A. 2007; 104(24):10122-7. PMC: 1891238. DOI: 10.1073/pnas.0700269104. View

Denkers E . T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii. Microbes Infect. 1999; 1(9):699-708. DOI: 10.1016/s1286-4579(99)80071-9. View

Denkers E, Gazzinelli R . Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev. 1998; 11(4):569-88. PMC: 88897. DOI: 10.1128/CMR.11.4.569. View

Quinones M, Estrada C, Jimenez F, Martinez H, Willmon O, Kuziel W . CCL2-independent role of CCR2 in immune responses against Leishmania major. Parasite Immunol. 2007; 29(4):211-7. DOI: 10.1111/j.1365-3024.2006.00935.x. View

Adams L, Hibbs Jr J, Taintor R, Krahenbuhl J . Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol. 1990; 144(7):2725-9. View

Silva N, Tafuri W, Alvarez-Leite J, Mineo J, Gazzinelli R . Toxoplasma gondii: in vivo expression of BAG-5 and cyst formation is independent of TNF p55 receptor and inducible nitric oxide synthase functions. Microbes Infect. 2002; 4(3):261-70. DOI: 10.1016/s1286-4579(02)01537-x. View

10.

Bernardes E, Silva N, Ruas L, Mineo J, Loyola A, Hsu D . Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity. Am J Pathol. 2006; 168(6):1910-20. PMC: 1606628. DOI: 10.2353/ajpath.2006.050636. View

11.

Liesenfeld O . Immune responses to Toxoplasma gondii in the gut. Immunobiology. 2000; 201(2):229-39. DOI: 10.1016/S0171-2985(99)80063-1. View

12.

Aliberti J, Valenzuela J, Carruthers V, Hieny S, Andersen J, Charest H . Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol. 2003; 4(5):485-90. DOI: 10.1038/ni915. View

13.

Strack A, Asensio V, Campbell I, Schluter D, Deckert M . Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma. Acta Neuropathol. 2002; 103(5):458-68. DOI: 10.1007/s00401-001-0491-7. View

14.

Peters W, Scott H, Chambers H, Flynn J, Charo I, Ernst J . Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2001; 98(14):7958-63. PMC: 35450. DOI: 10.1073/pnas.131207398. View

15.

Bonecchi R, Bianchi G, Bordignon P, DAmbrosio D, Lang R, Borsatti A . Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998; 187(1):129-34. PMC: 2199181. DOI: 10.1084/jem.187.1.129. View

16.

Kurihara T, Warr G, Loy J, Bravo R . Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med. 1997; 186(10):1757-62. PMC: 2199145. DOI: 10.1084/jem.186.10.1757. View

17.

Luangsay S, Kasper L, Rachinel N, Minns L, Mennechet F, Vandewalle A . CCR5 mediates specific migration of Toxoplasma gondii-primed CD8 lymphocytes to inflammatory intestinal epithelial cells. Gastroenterology. 2003; 125(2):491-500. DOI: 10.1016/s0016-5085(03)00903-x. View

18.

Van Coillie E, Van Damme J, Opdenakker G . The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev. 1999; 10(1):61-86. DOI: 10.1016/s1359-6101(99)00005-2. View

19.

Mennechet F, Kasper L, Rachinel N, Minns L, Luangsay S, Vandewalle A . Intestinal intraepithelial lymphocytes prevent pathogen-driven inflammation and regulate the Smad/T-bet pathway of lamina propria CD4+ T cells. Eur J Immunol. 2004; 34(4):1059-67. DOI: 10.1002/eji.200324416. View

20.

Langermans J, van der Hulst M, Nibbering P, Hiemstra P, Fransen L, Van Furth R . IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J Immunol. 1992; 148(2):568-74. View